Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


20.03.2017

1 Am J Pathol
1 Biochem Biophys Res Commun
1 BMC Cancer
1 BMC Gastroenterol
1 Cancer Res
4 Eur Radiol
3 Gastroenterology
1 Gut
4 Hepatology
1 J Comput Assist Tomogr
1 J Gastroenterol Hepatol
2 J Hepatol
1 Oncogene
2 PLoS One
2 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. HU B, Li Y, Gao L, Guo Y, et al
    Hepatic Induction of Fatty Acid Binding Protein 4 Plays a Pathogenic Role in Sepsis in Mice.
    Am J Pathol. 2017 Mar 6. pii: S0002-9440(17)30194.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. LV F, Wu J, Miao D, An W, et al
    p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress.
    Biochem Biophys Res Commun. 2017 Mar 9. pii: S0006-291X(17)30480.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. LEE JW, Choi MH, Lee YJ, Ali B, et al
    Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection.
    BMC Cancer. 2017;17:185.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  4. PERSICO M, Masarone M, Damato A, Ambrosio M, et al
    "Non alcoholic fatty liver disease and eNOS dysfunction in humans".
    BMC Gastroenterol. 2017;17:35.
    PubMed     Text format     Abstract available


    Cancer Res

  5. LIN DC, Mayakonda A, Dinh HQ, Huang P, et al
    Genomic and epigenomic heterogeneity of hepatocellular carcinoma.
    Cancer Res. 2017 Feb 20. pii: canres.2822.2016.
    PubMed     Text format     Abstract available


    Eur Radiol

  6. GHOLAMREZANEZHAD A, Mirpour S, Geschwind JF, Rao P, et al
    Evaluation of 70-150-mum doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model.
    Eur Radiol. 2016;26:3474-82.
    PubMed     Text format     Abstract available

  7. SCHMEEL FC, Simon B, Sabet A, Luetkens JA, et al
    Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
    Eur Radiol. 2017;27:966-975.
    PubMed     Text format     Abstract available

  8. LV P, Liu J, Yan X, Chai Y, et al
    CT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours.
    Eur Radiol. 2017;27:918-926.
    PubMed     Text format     Abstract available

  9. LI WD, Yu HY, Qian AM, Rong JJ, et al
    Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: A retrospective analysis of a large cohort.
    Eur Radiol. 2017;27:1227-1237.
    PubMed     Text format     Abstract available


    Gastroenterology

  10. NASR P, Forsgren MF, Ignatova S, Dahlstrom N, et al
    Using a 3% Proton Density Fat Fraction as a Cut-off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results from Histopathology Analysis.
    Gastroenterology. 2017 Mar 9. pii: S0016-5085(17)30267.
    PubMed     Text format     Abstract available

  11. CHEN B, Wei W, Ma L, Yang B, et al
    Computational Discovery of Niclosamide Ethanolamine, A Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells in Vitro and in Mice by Inhibiting CDC37 Signaling.
    Gastroenterology. 2017 Mar 8. pii: S0016-5085(17)30264.
    PubMed     Text format     Abstract available

  12. SERPER M, Taddei TH, Mehta R, D'Addeo K, et al
    Association of Provider Specialty and Multi-disciplinary Care with Hepatocellular Carcinoma Treatment and Mortality.
    Gastroenterology. 2017 Mar 7. pii: S0016-5085(17)30265.
    PubMed     Text format     Abstract available


    Gut

  13. PARES A
    Juan Rodes. A successful and extraordinary life of a visionary hepatologist.
    Gut. 2017;66:736.
    PubMed     Text format    


    Hepatology

  14. FLORIMONTE L, Iavarone M, Castellani M, Longo M, et al
    Uncommon extrahepatic metastases from hepatocellular carcinoma.
    Hepatology. 2017 Mar 10. doi: 10.1002/hep.29147.
    PubMed     Text format    

  15. HE Y, Feng D, Li M, Gao Y, et al
    Hepatic mtDNA-TLR9-microRNA-223 forms a negative feedback loop to limit neutrophil over-activation and acetaminophen hepatotoxicity.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29153.
    PubMed     Text format     Abstract available

  16. YANG Y, Zhou Y, Hou J, Bai C, et al
    Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29156.
    PubMed     Text format     Abstract available

  17. SINCLAIR M, Schelleman A, Sandhu D, Angus PW, et al
    Regression of hepatocellular adenomas and systemic inflammatory syndrome after cessation of estrogen therapy.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29151.
    PubMed     Text format     Abstract available


    J Comput Assist Tomogr

  18. WIMMER T, Steiner J, Talakic E, Stauber R, et al
    Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
    J Comput Assist Tomogr. 2017 Mar 15. doi: 10.1097/RCT.0000000000000592.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  19. KUO YH, Wang JH, Hung CH, Rau KM, et al
    The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib.
    J Gastroenterol Hepatol. 2017 Mar 11. doi: 10.1111/jgh.13783.
    PubMed     Text format     Abstract available


    J Hepatol

  20. BRUIX J, Reig M, Sangro B
    Assessment of treatment efficacy in hepatocellular carcinoma: response rate, delay in progression or none of them.
    J Hepatol. 2017 Mar 8. pii: S0168-8278(17)30133.
    PubMed     Text format    

  21. TAI WT, Cheng AL, Shiau CW, Huang HP, et al
    Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".
    J Hepatol. 2017 Mar 13. pii: S0168-8278(17)30118.
    PubMed     Text format    


    Oncogene

  22. DENG L, Tang J, Yang H, Cheng C, et al
    MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    PLoS One

  23. SHEARN CT, Orlicky DJ, McCullough RL, Jiang H, et al
    Liver-Specific Deletion of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Significantly Ameliorates Chronic EtOH-Induced Increases in Hepatocellular Damage.
    PLoS One. 2016;11:e0154152.
    PubMed     Text format     Abstract available

  24. SANTAREM OL, Cleva Rd, Sasaya FM, Assumpcao MS, et al
    Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension.
    PLoS One. 2016;11:e0154011.
    PubMed     Text format     Abstract available


    Transplantation

  25. BHATI C, Idowu MO, Sanyal AJ, Rivera M, et al
    Long Term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis Related Cirrhosis.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001709.
    PubMed     Text format     Abstract available

  26. MURALI AR, Patil S, Phillips KT, Voigt M, et al
    Locoregional Therapy with Curative Intent versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-analysis.
    Transplantation. 2017 Mar 10. doi: 10.1097/TP.0000000000001730.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: